1,787
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Application of CE–MS to A Metabonomics Study of Human Urine from Cigarette Smokers and Non-Smokers

, &
Pages 2733-2749 | Published online: 21 Nov 2014

References

  • Perfetti TA , RodgmanA. The complexity of tobacco and tobacco smoke. Contributions to tobacco research. Beitr. Tabakforsch24 (5), 215–232 (2011).
  • Food and Drug Administration (FDA) . Harmful and potentially harmful constituents in tobacco products and tobacco smoke; established list. www.fda.gov/TobaccoProducts/GuidanceComplianceRegulatoryInformation/ucm297786.htm.
  • Hatsukami DK , SladeJ, BenowitzNLet al. Reducing tobacco harm: research challenges and issues. Nicotine Tob. Res. 4 (2), S89–S101 (2002).
  • Zeller M , HatsukamiD. Strategic dialogue on tobacco harm reduction G: the strategic dialogue on tobacco harm reduction: a vision and blueprint for action in the US. Tob. Control18 (4), 324–332 (2009).
  • Debethizy JD , BorgerdingMF, DoolittleDJet al. Chemical and biological studies of a cigarette that heats rather than burns tobacco. J. Clin. Pharmacol. 30 (8), 755–763 (1990).
  • Leischow SJ , ZellerM, BackingerCL. Research priorities and infrastructure needs of the Family Smoking Prevention and Tobacco Control Act: science to inform FDA policy. Nicotine Tob. Res. 14 (1), 1–6 (2012).
  • Atkinson AJ , ColburnWA, DeGruttolaVG, DeMetsDLet al. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 69 (3), 89–95 (2001).
  • Gyorffy E , AnnaL, KovacsKet al. Correlation between biomarkers of human exposure to genotoxins with focus on carcinogen-DNA adducts. Mutagenesis23 (1), 1–18 (2008).
  • Hecht SS . Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat. Rev. Cancer3 (10), 733–744 (2003).
  • Gregg EO , MinetE, McewanM. Urinary biomarkers of smokers’ exposure to tobacco smoke constituents in tobacco products assessment: a fit for purpose approach. Biomarkers18 (6), 467–486 (2013).
  • Nicholson JK , LindonJC, HolmesE. ‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica29 (11), 1181–1189 (1999).
  • Bjerrum JT , NielsenOH, HaoFet al. Metabonomics in ulcerative colitis: diagnostics, biomarker identification, and insight into the pathophysiology. J. Proteome Res. 9 (2), 954–962 (2010).
  • Chan EC , KohPK, MalMet al. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). J. Proteome Res. 8 (1), 352–361 (2009).
  • Holmes E , BonnerFW, SweatmanBCet al. Nuclear magnetic resonance spectroscopy and pattern recognition analysis of the biochemical processes associated with the progression of and recovery from nephrotoxic lesions in the rat induced by mercury(II) chloride and 2-bromoethanamine. Mol. Pharmacol. 42 (5), 922–930 (1992).
  • Ikeda A , NishiumiS, ShinoharaMet al. Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer. Biomed. Chrom. 26 (5), 548–558 (2012).
  • Lindon JC , HolmesE, BollardMEet al. Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Biomarkers9 (1), 1–31 (2004).
  • Moolenaar SH , EngelkeUF, WeversRA. Proton nuclear magnetic resonance spectroscopy of body fluids in the field of inborn errors of metabolism. Ann. Clin. Biochem. 40 (Pt 1), 16–24 (2003).
  • Sitter B , SonnewaldU, SpraulMet al. High-resolution magic angle spinning MRS of breast cancer tissue. NMR Biomed. 15 (5), 327–337 (2002).
  • Clayton TA , BakerD, LindonJCet al. Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc. Natl Acad. Sci. 106 (34), 14728–14733 (2009).
  • Clayton TA , LindonJC, CloarecOet al. Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature440 (7087), 1073–1077 (2006).
  • Athersuch TJ . The role of metabolomics in characterizing the human exposome. Bioanalysis4 (18), 2207–2212 (2012).
  • Ellis JK , AthersuchTJ, ThomasLDet al. Metabolic profiling detects early effects of environmental and lifestyle exposure to cadmium in a human population. BMC Med. 10, 61 (2012).
  • Wishart DS . Advances in metabolite identification. Bioanalysis3 (15), 1769–1782 (2011).
  • Beckonert O , KeunHC, EbbelsTMet al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat. Protoc. 2 (11), 2692–2703 (2007).
  • Want EJ , WilsonID, GikaHet al. Global metabolic profiling procedures for urine using UPLC-MS. Nat. Protoc. 5 (6), 1005–1018 (2010).
  • Garcia-Perez I , Couto AlvesA, AnguloSet al. Bidirectional correlation of NMR and capillary electrophoresis fingerprints: a new approach to investigating Schistosoma mansoni infection in a mouse model. Anal. Chem. 82 (1), 203–210 (2009).
  • Lindon JC , NicholsonJK. Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics. Annu. Rev. Anal. Chem. 1, 45–69 (2008).
  • Lenz EM , WilsonID. Analytical strategies in metabonomics. J. Proteome Res. 6 (2), 443–458 (2007).
  • Scalbert A , BrennanL, FiehnOet al. Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research. Metabolomics5 (4), 435–458 (2009).
  • Zhang A , SunH, WangPet al. Modern analytical techniques in metabolomics analysis. Analyst137 (2), 293–300 (2012).
  • Song H , WangL, LiuHLet al. Tissue metabolomic fingerprinting reveals metabolic disorders associated with human gastric cancer morbidity. Oncol. Rep. 26 (2), 431–438 (2011).
  • Vallejo M , GarciaA, TunonJet al. Plasma fingerprinting with GC-MS in acute coronary syndrome. Anal. Bioanal. Chem. 394 (6), 1517–1524 (2009).
  • Mueller DC , PillerM, NiessnerRet al. Untargeted metabolomic profiling in saliva of smokers and non-smokers by a validated GC-TOF-MS method. J. Proteome Res. 13 (3), 1602–1613 (2014).
  • Garcia-Perez I , VallejoM, GarciaAet al. Metabolic fingerprinting with capillary electrophoresis. J. Chromatogr. A1204 (2), 130–139 (2008).
  • Ramautar R , SomsenGW, De JongGJ. CE-MS in metabolomics. Electrophoresis30 (1), 276–291 (2009).
  • Monton MR , SogaT. Metabolome analysis by capillary electrophoresis-mass spectrometry. J. Chromatogr. A1168 (1–2), 237–246 (2007).
  • Ramautar R , MayborodaOA, SomsenGWet al. CE-MS for metabolomics: developments and applications in the period 2008–2010. Electrophoresis32 (1), 52–65 (2011).
  • Ramautar R , SomsenGW, De JongGJ. CE-MS for metabolomics: developments and applications in the period 2010–2012. Electrophoresis34 (1), 86–98 (2013).
  • Saric J , WantEJ, DuthalerUet al. Systematic evaluation of extraction methods for multiplatform-based metabotyping: application to the Fasciola hepatica metabolome. Anal. Chem. 84 (16), 6963–6972 (2012).
  • Simo C , BarbasC, CifuentesA. Capillary electrophoresis-mass spectrometry in food analysis. Electrophoresis26 (7–8), 1306–1318 (2005).
  • Muller DC , DegenC, SchererGet al. Metabolomics using GC-TOF-MS followed by subsequent GC-FID and HILIC-MS/MS analysis revealed significantly altered fatty acid and phospholipid species profiles in plasma of smokers. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 1 (966), 117–126 (2014).
  • Xu T , HolzapfelC, DongXet al. Effects of smoking and smoking cessation on human serum metabolite profile: results from the KORA cohort study. BMC Med. 11, 60 (2013).
  • Hsu PC , ZhouB, ZhaoYet al. Feasibility of identifying the tobacco-related global metabolome in blood by UPLC-QTOF-MS. J. Proteome Res. 12 (2), 679–691 (2013).
  • Ryan D , RobardsK, PrenzlerPDet al. Recent and potential developments in the analysis of urine: a review. Anal. Chim. Acta684 (1–2), 8–20 (2011).
  • Shepperd CJ , EldridgeAC, MarinerDCet al. A study to estimate and correlate cigarette smoke exposure in smokers in Germany as determined by filter analysis and biomarkers of exposure. Regul. Toxicol. Pharmacol. 55 (1), 97–109 (2009).
  • Maher AD , ZirahSF, HolmesEet al. Experimental and analytical variation in human urine in 1H NMR spectroscopy-based metabolic phenotyping studies. Anal. Chem. 79 (14), 5204–5211 (2007).
  • The Handbook of Metabonomics and Metabolomics . LindonJC, NicholsonJK, HolmesE ( Eds). Elsevier, The Netherlands (2000).
  • Riboli E , HaleyNJ, De WaardFet al. Validity of urinary biomarkers of exposure to tobacco smoke following prolonged storage. Int. J. Epidemiol. 24 (2), 354–358 (1995).
  • Xia Y , BernertJT. Stability of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine samples stored at various temperatures. J. Anal. Toxicol. 34 (7), 411–415 (2010).
  • Gika HG , MacphersonE, TheodoridisGAet al. Evaluation of the repeatability of ultra-performance liquid chromatography-TOF-MS for global metabolic profiling of human urine samples. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 871 (2), 299–305 (2008).
  • Halimi JM , GiraudeauB, VolSet al. Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population. Kidney Int. 58 (3), 1285–1292 (2000).
  • Smith CA , O’mailleG, WantEJet al. METLIN – A metabolite mass spectral database. Ther. Drug Monit. 27 (6), 747–751 (2005).
  • Wishart DS , KnoxC, GuoACet al. HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res. 37, D603–D610 (2009).
  • Baidoo EE , ClenchMR, SmithRFet al. Determination of nicotine and its metabolites in urine by solid-phase extraction and sample stacking capillary electrophoresis-mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 796 (2), 303–313 (2003).
  • Fisher RA . In : Statistical Methods for Research Workers, Oliver and Boyd, Edinburgh, UK (1925).
  • Spitale RC , ChengMY, ChunKAet al. Differential effects of dietary supplements on metabolomic profile of smokers versus non-smokers. Genome Med. 4 (2), 14 (2012).
  • Kozlowski LT , PillitteriJL, SweeneyCT. Misuse of “light” cigarettes by means of vent blocking. J. Subst. Abuse6 (3), 333–336 (1994).
  • Djordjevic MV , StellmanSD, ZangE. Doses of nicotine and lung carcinogens delivered to cigarette smokers. J. Natl. Cancer Inst. 92 (2), 106–111 (2000).
  • Hecht SS , MurphySE, CarmellaSGet al. Similar uptake of lung carcinogens by smokers of regular, light, and ultralight cigarettes. Cancer Epidemiol. Biomarkers14 (3), 693–698 (2005).
  • Stieber J , HartelU, HellerWDet al. Smoking habits and attitude to smoking in the study population of the MONICA Project Augsburg. Soz. Praventivmed. 33 (1), 22–26 (1988).
  • Lu SC . Regulation of hepatic glutathione synthesis: current concepts and controversies. FASEB J. 13 (10), 1169–1183 (1999).
  • Wendel A , HahnR, GuderWG. On the role of gamma-glutamyltransferase in renal tubular amino acid reabsorption. Curr. Probl. Clin. Biochem. 6, 426–436 (1976).
  • Vulimiri SV , MisraM, HammJTet al. Effects of mainstream cigarette smoke on the global metabolome of human lung epithelial cells. Chem. Res. Toxicol. 22 (3), 492–503 (2009).
  • Tanriverdi H , EvrengulH, KuruOet al. Cigarette smoking induced oxidative stress may impair endothelial function and coronary blood flow in angiographically normal coronary arteries. Circ. J. 70 (5), 593–599 (2006).
  • Rahman Q , AbidiP, AfaqFet al. Glutathione redox system in oxidative lung injury. Crit. Rev. Toxicol. 29 (6), 543–568 (1999).
  • Vibhuti A , ArifE, DeepakDet al. Correlation of oxidative status with BMI and lung function in COPD. Clin. Biochem. 40 (13–14), 958–963 (2007).
  • Toth KM , BergerEM, BeehlerCJet al. Erythrocytes from cigarette smokers contain more glutathione and catalase and protect endothelial cells from hydrogen peroxide better than do erythrocytes from nonsmokers. Am. Rev. Respir. 134 (2), 281–284 (1986).
  • Rahman I , MacneeW. Lung glutathione and oxidative stress: implications in cigarette smoke-induced airway disease. Am. J. Physiol. 277 (6 Pt 1), L1067–1088 (1999).
  • Gould NS , MinE, GauthierSet al. Lung glutathione adaptive responses to cigarette smoke exposure. Respir. Res. 12, 133 (2011).
  • Rahman I , Van SchadewijkAA, HiemstraPSet al. Localization of gamma-glutamylcysteine synthetase messenger RNA expression in lungs of smokers and patients with chronic obstructive pulmonary disease. Free Radic. Biol. Med. 28 (6), 920–925 (2000).
  • Larsson A , MattssonB. On the mechanism of 5-oxoproline overproduction in 5-oxoprolinuria. Clin. Chim. Acta67 (3), 245–253 (1976).
  • Forrester TE , BadalooV, BennettFIet al. Excessive excretion of 5-oxoproline and decreased levels of blood glutathione in type II diabetes mellitus. Eur. J. Clin. Nutr. 44 (11), 847–850 (1990).
  • Van Der Werf P , GriffithOW, MeisterA. 5-Oxo-l-prolinase (L-pyroglutamate hydrolase). Purification and catalytic properties. J. Biol. Chem. 250 (17), 6686–6692 (1975).
  • Soga T , BaranR, SuematsuMet al. Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption. J. Biol. Chem. 281 (24), 16768–16776 (2006).
  • Luppi F , AarbiouJ, Van WeteringSet al. Effects of cigarette smoke condensate on proliferation and wound closure of bronchial epithelial cells in vitro: role of glutathione. Resp. Res. 6, 140 (2005).
  • Vibhuti A , ArifE, DeepakDet al. Correlation of oxidative status with BMI and lung function in COPD. Clin. Biochem. 40 (13–14), 958–963 (2007).
  • Jenks BH , MckeeRW, SwendseidMEet al. Methylated niacin derivatives in plasma and urine after an oral dose of nicotinamide given to subjects fed a low-methionine diet. Am. J. Clin. Nutr. 46 (3), 496–502 (1987).
  • Surjana D , HallidayGM, DamianDL. Role of nicotinamide in DNA damage, mutagenesis, and DNA repair. J. Nucleic Acids2010, 157591 (2010).
  • Rocha CM , CarrolaJ, BarrosASet al. Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of blood plasma. J. Proteome Res. 10 (9), 4314–4324 (2011).
  • Srivastava S , RoyR, SinghSet al. Taurine – a possible fingerprint biomarker in non-muscle invasive bladder cancer: A pilot study by 1H NMR spectroscopy. Cancer Biomark6 (1), 11–20 (2010).
  • Travis WD et al. Cancer IaFRO, Pathology IaO. In : Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. IARC Press, Lyon, France (2004).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.